Literature DB >> 9452405

Laboratory survey of drug-resistant Streptococcus pneumoniae in New York City, 1993-1995.

R Heffernan1, K Henning, A Labowitz, A Hjelte, M Layton.   

Abstract

Wide geographic variation in the prevalence of drug-resistant Streptococcus pneumoniae demonstrates the importance of tracking antimicrobial resistance locally. This survey of hospital microbiology laboratories in New York City found that penicillin resistance (MIC > or = 2.0 micrograms/ml) increased from 1.5% of S. pneumoniae isolates in 1993 to 6.3% in 1995 and that in 1995, one-third of isolates nonsusceptible to penicillin (MIC > or = 0.1 microgram/ml) were also nonsusceptible to an extended-spectrum cephalosporin (MIC > or = 1 microgram/ml).

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9452405      PMCID: PMC2627676          DOI: 10.3201/eid0401.980116

Source DB:  PubMed          Journal:  Emerg Infect Dis        ISSN: 1080-6040            Impact factor:   6.883


  9 in total

Review 1.  Epidemiology and in vitro susceptibility of drug-resistant Streptococcus pneumoniae.

Authors:  P C Appelbaum
Journal:  Pediatr Infect Dis J       Date:  1996-10       Impact factor: 2.129

2.  Antimicrobial resistance of Streptococcus pneumoniae recovered from outpatients in the United States during the winter months of 1994 to 1995: results of a 30-center national surveillance study.

Authors:  G V Doern; A Brueggemann; H P Holley; A M Rauch
Journal:  Antimicrob Agents Chemother       Date:  1996-05       Impact factor: 5.191

3.  The continued emergence of drug-resistant Streptococcus pneumoniae in the United States: an update from the Centers for Disease Control and Prevention's Pneumococcal Sentinel Surveillance System.

Authors:  J C Butler; J Hofmann; M S Cetron; J A Elliott; R R Facklam; R F Breiman
Journal:  J Infect Dis       Date:  1996-11       Impact factor: 5.226

Review 4.  Antimicrobial resistance in Streptococcus pneumoniae: can immunization prevent its spread?

Authors:  R S Munford; T V Murphy
Journal:  J Investig Med       Date:  1994-12       Impact factor: 2.895

5.  Action plan for drug-resistant Streptococcus pneumoniae. The DRSP Working Group.

Authors:  M S Cetron; D B Jernigan; R F Breiman
Journal:  Emerg Infect Dis       Date:  1995 Apr-Jun       Impact factor: 6.883

6.  Risk factors for carriage of drug-resistant Streptococcus pneumoniae among children in Memphis, Tennessee.

Authors:  K E Arnold; R J Leggiadro; R F Breiman; H B Lipman; B Schwartz; M A Appleton; K O Cleveland; H C Szeto; B C Hill; F C Tenover; J A Elliott; R R Facklam
Journal:  J Pediatr       Date:  1996-06       Impact factor: 4.406

7.  Emergence of drug-resistant pneumococcal infections in the United States.

Authors:  R F Breiman; J C Butler; F C Tenover; J A Elliott; R R Facklam
Journal:  JAMA       Date:  1994-06-15       Impact factor: 56.272

8.  Penicillin- and cephalosporin-resistant strains of Streptococcus pneumoniae causing sepsis and meningitis in children with sickle cell disease.

Authors:  P J Chesney; J A Wilimas; G Presbury; S Abbasi; R J Leggiadro; Y Davis; S W Day; G E Schutze; W C Wang
Journal:  J Pediatr       Date:  1995-10       Impact factor: 4.406

9.  The prevalence of drug-resistant Streptococcus pneumoniae in Atlanta.

Authors:  J Hofmann; M S Cetron; M M Farley; W S Baughman; R R Facklam; J A Elliott; K A Deaver; R F Breiman
Journal:  N Engl J Med       Date:  1995-08-24       Impact factor: 91.245

  9 in total
  5 in total

1.  Use of the National Committee for Clinical Laboratory Standards guidelines for disk diffusion susceptibility testing in New York state laboratories.

Authors:  J A Kiehlbauch; G E Hannett; M Salfinger; W Archinal; C Monserrat; C Carlyn
Journal:  J Clin Microbiol       Date:  2000-09       Impact factor: 5.948

2.  High prevalence of penicillin-nonsusceptible Streptococcus pneumoniae at a community hospital in Oklahoma.

Authors:  R L Moolenaar; R Pasley-Shaw; J R Harkess; A Lee; J M Crutcher
Journal:  Emerg Infect Dis       Date:  2000 May-Jun       Impact factor: 6.883

3.  Streptococcus pneumoniae, Brooklyn, New York: fluoroquinolone resistance at our doorstep.

Authors:  John Quale; David Landman; Jayashree Ravishankar; Carlos Flores; Simona Bratu
Journal:  Emerg Infect Dis       Date:  2002-06       Impact factor: 6.883

4.  Tracking drug-resistant Streptococcus pneumoniae in Oregon: an alternative surveillance method.

Authors:  A E Chin; K Hedberg; P R Cieslak; M Cassidy; K R Stefonek; D W Fleming
Journal:  Emerg Infect Dis       Date:  1999 Sep-Oct       Impact factor: 6.883

5.  Aggregated antibiograms and monitoring of drug-resistant Streptococcus pneumoniae.

Authors:  Chris A Van Beneden; Catherine Lexau; Wendy Baughman; Brenda Barnes; Nancy Bennett; P Maureen Cassidy; Margaret Pass; Lisa Gelling; Nancy L Barrett; Elizabeth R Zell; Cynthia G Whitney
Journal:  Emerg Infect Dis       Date:  2003-09       Impact factor: 6.883

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.